The Effect of Reading Fairy Tales and Coloring on Children's Fear Level in Children Who Are Administered Inhaler Medication With a Mask.

June 30, 2024 updated by: Nuray Macuncu, Trakya University

The Effect of Reading Fairy Tales and Coloring on Children's Fear Level and Parental Health Care Satisfaction in Children Aged 3-6 Years Who Are Administered Inhaler Drugs

This thesis study was conducted as an unblinded, randomized controlled experiment to examine the effects of reading and coloring fairy tales, which can be used during inhaler medication administration with a mask, on children's fear level and parental health care satisfaction.

Study Overview

Status

Completed

Detailed Description

Data were collected at Edirne Sultan 1. Murat State Hospital Pediatrics Clinic between September 2023 and January 2024. Children aged 3-6 were included in the study. In the research, the sample was divided into three groups. 99 children participated in the study, 33 children in each group. Using the randomization program, it was determined which sample group the children would be included in.

In the study, reading fairy tales and coloring were used as distraction methods for the experimental group. Inhaler medication was administered via mask to the control group without any application. The implementation period of the research lasted an average of four months. Necessary ethical permissions were obtained before the research. In the study, the Child Fear Scale was used to measure the level of fear, the PedsQL Health Care Satisfaction Scale was used to measure parental satisfaction, and the Children's Emotional Indicators Scale was used to measure emotional indicators. Explanatory information about the application was given to the children and their parents by the researcher, and they were voluntarily informed and signed a consent form. Research data were collected by the researcher by meeting children and parents face to face.

Study Type

Interventional

Enrollment (Actual)

99

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Merkez
      • Edirne, Merkez, Turkey
        • Türkiye

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Parent and child volunteering to participate in the study,
  2. The child is between the ages of 3-6,
  3. Being admitted due to respiratory system disease,
  4. Inhaler treatment with a mask will be applied.

Exclusion Criteria:

  1. Parent and child not voluntarily participating in the study,
  2. The child has any genetic, congenital, chronic or metabolic disease,
  3. The child has vision, hearing and speech problems,
  4. The child's vital signs are unstable (no fever, tachypnea, etc.) and the need for any emergency intervention.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: distraction methods
reading fairy tales
Reading fairy tales during inhaler medication administration.
Experimental: distraction method
painting
painting during inhaler medication administration
No Intervention: Control Grup
Routine Treatment Group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Personal data collection form
Time Frame: baseline
The data collection form was prepared by the researchers in line with the literature. In this form 8 questions about the characteristics of children.There are 18 questions in total, 10 of which include parent and family characteristics.
baseline
Child Fear Scale
Time Frame: baseline
The scale was developed to determine the anxiety level of children aged 5-10 years. There are various facial expressions in the scale and a numerical value is given for each facial expression. The lowest score obtained from the scale is "0" and the highest score is "4". The higher the score obtained from the scale, the higher the level of anxiety felt in the child. The inhaler was filled by the child before medication administration.
baseline
Child Emotional Manifestation Scale
Time Frame: baseline
In the scale, emotional indicators are evaluated in terms of 5 parameters. These parameters are; facial expression, voice, activity, interaction and cooperation level. These five parameters are scored from 1 to 5, and the lowest "5" and the highest "25" points are obtained at the end of the evaluation of the scale. A low score from the scale indicates a positive emotional state, and an increase in a score indicates a negative emotional state. The inhaler was filled out by the researcher before drug administration.
baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Child Fear Scale
Time Frame: within 10 minutes after inhaler treatment
In the scale, emotional indicators are evaluated in terms of 5 parameters. These parameters are; facial expression, voice, activity, interaction and cooperation level. These five parameters are scored from 1 to 5, and the lowest "5" and the highest "25" points are obtained at the end of the evaluation of the scale. A low score from the scale indicates a positive emotional state, and an increase in a score indicates a negative emotional state. the inhaler was filled by the child within 10 minutes of treatment
within 10 minutes after inhaler treatment
Child Emotional Manifestation Scale
Time Frame: within 10 minutes after inhaler treatment
In the scale, emotional indicators are evaluated in terms of 5 parameters. These parameters are; facial expression, voice, activity, interaction and cooperation level. These five parameters are scored from 1 to 5, and the lowest "5" and the highest "25" points are obtained at the end of the evaluation of the scale. A low score from the scale indicates a positive emotional state, and an increase in a score indicates a negative emotional state. inhaler was filled by the researcher within 10 minutes of treatment
within 10 minutes after inhaler treatment
PedsQL Health Care Parental Satisfaction Scale
Time Frame: within 10 minutes after inhaler treatment
This scale was created to evaluate parents' satisfaction with health care and to increase the level of satisfaction with health care; It consists of six subheadings and 25 questions: information, family participation, communication, technical skills, emotional needs and general satisfaction. The statements in the PedsQL Health Care Satisfaction Scale are; never satisfied = 0, sometimes satisfied = 25, It was quantified with a score of most of the time = 50, almost always satisfied = 75, always satisfied = 100 points. inhaler filled by parent within 10 minutes of treatment
within 10 minutes after inhaler treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2023

Primary Completion (Actual)

January 20, 2024

Study Completion (Actual)

January 20, 2024

Study Registration Dates

First Submitted

March 12, 2024

First Submitted That Met QC Criteria

June 30, 2024

First Posted (Actual)

July 3, 2024

Study Record Updates

Last Update Posted (Actual)

July 3, 2024

Last Update Submitted That Met QC Criteria

June 30, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • TÜTF-GOBAEK 2022/318

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Satisfaction

Clinical Trials on reading fairy tales

Subscribe